Results 11 to 20 of about 258,961 (214)

A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry. [PDF]

open access: yesHemasphere
HemaSphere, Volume 10, Issue 2, February 2026.
Puig N   +25 more
europepmc   +2 more sources

European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma. [PDF]

open access: yesHemasphere
Abstract Given the evolving understanding of genetic risk factors in multiple myeloma (MM), this paper assesses whether next‐generation sequencing (NGS) could complement or even replace fluorescence in situ hybridization (FISH) at diagnosis. A structured consensus process within European Myeloma Network (EMN) clinical and laboratory groups was ...
Bolli N   +31 more
europepmc   +2 more sources

European Expert Panel Consensus on Outpatient Administration of Teclistamab and Talquetamab in Patients With Multiple Myeloma: Feasibility, Key Considerations, and Future Directions. [PDF]

open access: yesEur J Haematol
ABSTRACT Objectives Teclistamab and talquetamab treatments are typically initiated in a hospital due to the potential risk of cytokine release syndrome. However, emerging data support the potential for outpatient administration (i.e., administration without overnight hospital admission).
Lund T   +12 more
europepmc   +2 more sources

High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy. [PDF]

open access: yesHemasphere
Abstract Patients with newly‐diagnosed multiple myeloma (MM) who experience early relapse (ER) have dismal overall survival (OS). Their prospective identification, either before or soon after treatment initiation, is paramount to use alternative approaches and prevent ER.
Manubens A   +33 more
europepmc   +2 more sources

30-Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis. [PDF]

open access: yesHemasphere
HemaSphere, Volume 8, Issue 11, November 2024.
Ocio EM   +12 more
europepmc   +2 more sources

High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience. [PDF]

open access: yesHemasphere
Abstract This study examines the impact of cytogenetic abnormalities and their co‐segregation on the prognosis of newly diagnosed multiple myeloma patients. The analysis included 1304 patients from four different GEM‐PETHEMA clinical trials. Genetic alterations, such as t(4;14), t(14;16), del(17p), +1q, and del(1p), were investigated using FISH on CD38
González-Calle V   +23 more
europepmc   +2 more sources

La construcción del ocio en adolescentes y su influencia en el desarrollo de trayectorias delictivas [PDF]

open access: yes, 2013
La construcción de actividades de ocio incide directamente en el desarrollo evolutivo de los adolescentes, capacitándolos para una sana socialización en sus espacios cotidianos.
Navarro Pérez, José Javier   +2 more
core   +5 more sources

Ocio festivo: Cambios relevantes en la percepción y organización de las fiestas

open access: yesArbor: Ciencia, Pensamiento y Cultura, 2012
Este artículo pretende apuntar la revalorización actual del ocio, destacando sus transformaciones en la sociedad contemporánea, abordando una faceta específica del fenómeno del ocio, como es su dimensión festiva.
Aurora Madariaga Ortuzar   +1 more
doaj   +1 more source

Ocio y cultura [PDF]

open access: yesCuadernos de arquitectura y urbanismo, 1971
Trias, Eugenio
core   +2 more sources

Espacios de ocio en la territorialidad Guaraní Kaiowá de Dourados, Mato Grosso do Sul, Brasil [PDF]

open access: yes, 2013
En Brasil la población indígena alcanza aproximadamente las 817 mil personas. En el Estado de Mato Grosso do Sul habita una gran parte de ellas: solamente el pueblo Guaraní y sus variedades suponen una población de 47 mil personas distribuidas en 26 ...
Casaro Nascimento, Adir   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy